Austin Health

Title
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
Publication Date
2024-02
Author(s)
Mackintosh, John A
Keir, Gregory
Troy, Lauren K
Holland, Anne E
Grainge, Christopher
Chambers, Daniel C
Sandford, Debra
Jo, Helen E
Glaspole, Ian
Wilsher, Margaret
Goh, Nicole S L
Reynolds, Paul N
Chapman, Sally
Mutsaers, Steven E
de Boer, Sally
Webster, Susanne
Moodley, Yuben
Corte, Tamera J
Subject
idiopathic pulmonary fibrosis
interstitial lung disease
progressive pulmonary fibrosis
pulmonary fibrosis
treatment
Type of document
Journal Article
OrcId
0000-0002-5254-4144
0000-0001-9979-8726
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-2061-845X
0000-0002-6565-9928
0000-0002-9553-5870
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-5118-2890
0000-0003-2046-8957
0000-0003-2065-4346
0000-0002-2273-1774
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-0777-1196
0000-0002-7096-9365
DOI
10.1111/resp.14656
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.
Link
Citation
Respirology (Carlton, Vic.) 2024-02; 29(2)
Jornal Title
Respirology (Carlton, Vic.)
ISSN
1440-1843

Files:

NameSizeformatDescriptionLink